Market Overview

UPDATE: Stifel Nicolaus Initiates Johnson & Johnson at Hold; Fairly Valued

Related JNJ
Bank Of America Remains Optimistic On Johnson & Johnson
Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson
U.S., U.K. ISIS Response Differ Widely (Fox Business)

Stifel Nicolaus initiated coverage on Johnson & Johnson (NYSE: JNJ) with a Hold rating.

Stifel Nicolaus noted, "We are initiating coverage of Johnson & Johnson (JNJ) with a Hold rating. We see JNJ as a core health care holding and total return vehicle in any environment for investors looking for safety and stability, particularly in these uncertain times. As JNJ continues to resolve recent issues and ex-FX sales growth reaccelerates modestly in each year over the next few years, JNJ shares should sustain its 12.6x forward P/E multiple, in line with the S&P 500."

Johnson & Johnson closed at $69.19 on Monday.

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (JNJ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters